4055

    531349

    PANACEABIO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PANACEA BIOTEC LTD Share Price Today

    PANACEA BIOTEC LTD is currently trading at ₹539.5, up by ₹1.95 from the previous close. The stock touched an intraday high of ₹550.70 and a low of ₹537.10 during the latest trading session. Over the past one year, PANACEA BIOTEC LTD has delivered a return of 33.97%, while the stock has declined 0.07% in the last one month.

    PANACEA BIOTEC LTD performance

    Today’s low Today’s high
    ₹ 537.10 ₹ 550.70
    ₹ 538.85
    52 week low 52 week high
    ₹ 292.40 ₹ 647.00
    ₹ 538.85
    Open Price ₹ 544.00
    Prev. Close ₹ 537.55
    Volume (Shares) 46448.00
    Total traded value ₹ 250.28
    Upper Circuit ₹ 591.30
    Lower Circuit ₹ 483.80
    info

    Investment Returns

    Over 1 Month -0.07% Over 3 Months 67.07% Over 6 Months 33.52% Over 1 Year 33.97%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PANACEA BIOTEC LTD fundamentals


    • Market cap (Cr) 3,303.30
    • P/E Ratio (TTM) -110.18
    • Beta 1.01
    • Book Value / share 46.56
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -0.18
    info icon alternate text
    • Market cap (Cr) 3,323.20
    • P/E Ratio (TTM) -110.18
    • Beta 0.83
    • Book Value / share 46.56
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -0.18
    info icon alternate text

    PANACEA BIOTEC LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 111.12
    Operating Expense 121.33
    Net Profit -0.18
    Net Profit Margin (%) -0.16
    Earnings Per Share (EPS) -0.03
    EBITDA 5.89
    Effective Tax Rate (%) 96.09
    Particulars DEC 2025 (Values in Cr)
    Revenue 99.31
    Operating Expense 112.62
    Net Profit -7.36
    Net Profit Margin (%) -7.41
    Earnings Per Share (EPS) -1.20
    EBITDA 2.45
    Effective Tax Rate (%) 22.28
    Particulars SEP 2025 (Values in Cr)
    Revenue 90.81
    Operating Expense 115.35
    Net Profit -15.64
    Net Profit Margin (%) -17.22
    Earnings Per Share (EPS) -2.55
    EBITDA -10.09
    Effective Tax Rate (%) 25.27
    Particulars JUN 2025 (Values in Cr)
    Revenue 112.25
    Operating Expense 126.04
    Net Profit -6.70
    Net Profit Margin (%) -5.96
    Earnings Per Share (EPS) -1.09
    EBITDA 1.92
    Effective Tax Rate (%) 24.20
    Particulars MAR 2025 (Values in Cr)
    Revenue 67.90
    Operating Expense 96.02
    Net Profit -12.39
    Net Profit Margin (%) -18.24
    Earnings Per Share (EPS) -2.02
    EBITDA -12.48
    Effective Tax Rate (%) 43.75
    Particulars MAR 2026 (Values in Cr)
    Revenue 413.49
    Operating Expense 475.34
    Net Profit -29.88
    Net Profit Margin (%) -7.22
    Earnings Per Share (EPS) -4.88
    EBITDA 0.19
    Effective Tax Rate (%) 31.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 309.85
    Operating Expense 352.53
    Net Profit -15.23
    Net Profit Margin (%) -4.91
    Earnings Per Share (EPS) -2.49
    EBITDA 9.69
    Effective Tax Rate (%) 41.55
    Particulars MAR 2024 (Values in Cr)
    Revenue 359.60
    Operating Expense 380.29
    Net Profit 3.55
    Net Profit Margin (%) 0.98
    Earnings Per Share (EPS) 0.58
    EBITDA 39.08
    Effective Tax Rate (%) 15.67
    Particulars MAR 2023 (Values in Cr)
    Revenue 257.07
    Operating Expense 354.25
    Net Profit -87.54
    Net Profit Margin (%) -34.05
    Earnings Per Share (EPS) -14.29
    EBITDA -28.18
    Effective Tax Rate (%) -39.50
    Particulars MAR 2022 (Values in Cr)
    Revenue 235.50
    Operating Expense 341.65
    Net Profit -93.58
    Net Profit Margin (%) -39.73
    Earnings Per Share (EPS) -15.28
    EBITDA -60.10
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 132.76
    ROE % -5.13
    ROCE % -4.31
    Total Debt to Total Equity 0.02
    EBITDA Margin -0.77
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 133.94
    ROE % -4.07
    ROCE % -3.34
    Total Debt to Total Equity 0.02
    EBITDA Margin 1.07
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 134.20
    ROE % -11.06
    ROCE % -9.50
    Total Debt to Total Equity 0.03
    EBITDA Margin -11.22
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 139.59
    ROE % -60.80
    ROCE % -5.11
    Total Debt to Total Equity 1.32
    EBITDA Margin -0.34
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -40.87
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 13.64
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 47.72
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.52
    EBITDA Margin 3.13
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 50.20
    ROE % 0.86
    ROCE % 3.26
    Total Debt to Total Equity 0.32
    EBITDA Margin 10.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 49.63
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.24
    EBITDA Margin -10.97
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 64.24
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.16
    EBITDA Margin -25.52
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 79.43
    ROE % -2.53
    ROCE % -1.10
    Total Debt to Total Equity 0.09
    EBITDA Margin 5.22
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 106.96
    Total Assets 1289.74
    Total Liabilities 1289.74
    Total Equity 830.61
    Share Outstanding 6
    Price to Book Ratio 9.23
    Return on Assets (%) -0.64
    Return on Capital (%) -0.98
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 139.48
    Total Assets 1240.67
    Total Liabilities 1240.67
    Total Equity 838.22
    Share Outstanding 6
    Price to Book Ratio 2.42
    Return on Assets (%) -0.09
    Return on Capital (%) -0.14
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 225.99
    Total Assets 1271.16
    Total Liabilities 1271.16
    Total Equity 840.11
    Share Outstanding 6
    Price to Book Ratio 2.18
    Return on Assets (%) -2.61
    Return on Capital (%) -3.86
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 583.27
    Total Assets 1758.86
    Total Liabilities 1758.86
    Total Equity 873.65
    Share Outstanding 6
    Price to Book Ratio 2.31
    Return on Assets (%) 61.30
    Return on Capital (%) 118.78
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 135.79
    Total Assets 1177.53
    Total Liabilities 1177.53
    Total Equity -231.69
    Share Outstanding 6
    Price to Book Ratio 2.23
    Return on Assets (%) -12.54
    Return on Capital (%) -25.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 62.16
    Total Assets 869.46
    Total Liabilities 869.46
    Total Equity 313.96
    Share Outstanding 6
    Price to Book Ratio 9.23
    Return on Assets (%) -1.75
    Return on Capital (%) -2.81
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 11.95
    Total Assets 753.79
    Total Liabilities 753.79
    Total Equity 329.14
    Share Outstanding 6
    Price to Book Ratio 2.42
    Return on Assets (%) 0.47
    Return on Capital (%) 0.78
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 43.25
    Total Assets 723.90
    Total Liabilities 723.90
    Total Equity 325.65
    Share Outstanding 6
    Price to Book Ratio 2.18
    Return on Assets (%) -12.09
    Return on Capital (%) -20.45
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 42.68
    Total Assets 761.83
    Total Liabilities 761.83
    Total Equity 415.09
    Share Outstanding 6
    Price to Book Ratio 2.31
    Return on Assets (%) -12.28
    Return on Capital (%) -18.74
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 88.96
    Total Assets 791.56
    Total Liabilities 791.56
    Total Equity 508.16
    Share Outstanding 6
    Price to Book Ratio 2.23
    Return on Assets (%) -1.82
    Return on Capital (%) -2.53
    Particulars MAR 2025 (Values in Cr)
    Net Income -7.94
    Cash from Operations -26.40
    Cash from Investing 64.98
    Cash from Financing -2.66
    Net change in Cash 34.95
    Free Cash Flow 23.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.47
    Cash from Operations 2.40
    Cash from Investing 10.22
    Cash from Financing -2.80
    Net change in Cash 7.31
    Free Cash Flow 80.12
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.80
    Cash from Operations -419.97
    Cash from Investing 430.33
    Cash from Financing -18.37
    Net change in Cash -10.49
    Free Cash Flow -379.02
    Particulars MAR 2022 (Values in Cr)
    Net Income 1449.35
    Cash from Operations 295.25
    Cash from Investing 1282.57
    Cash from Financing -1175.85
    Net change in Cash -1.72
    Free Cash Flow 307.76
    Particulars MAR 2021 (Values in Cr)
    Net Income -145.03
    Cash from Operations 107.75
    Cash from Investing -47.67
    Cash from Financing -47.11
    Net change in Cash 11.97
    Free Cash Flow 129.52
    Particulars MAR 2025 (Values in Cr)
    Net Income -26.05
    Cash from Operations 5.04
    Cash from Investing -60.60
    Cash from Financing 90.07
    Net change in Cash 33.41
    Free Cash Flow 58.01
    Particulars MAR 2024 (Values in Cr)
    Net Income 4.20
    Cash from Operations 34.95
    Cash from Investing -46.80
    Cash from Financing 12.81
    Net change in Cash -0.91
    Free Cash Flow 110.47
    Particulars MAR 2023 (Values in Cr)
    Net Income -62.75
    Cash from Operations -9.65
    Cash from Investing 2.41
    Cash from Financing 9.00
    Net change in Cash 0.67
    Free Cash Flow 28.72
    Particulars MAR 2022 (Values in Cr)
    Net Income -93.57
    Cash from Operations -51.86
    Cash from Investing 39.54
    Cash from Financing 9.82
    Net change in Cash -3.32
    Free Cash Flow -43.81
    Particulars MAR 2021 (Values in Cr)
    Net Income -12.88
    Cash from Operations 39.24
    Cash from Investing -37.32
    Cash from Financing -7.20
    Net change in Cash -6.25
    Free Cash Flow 53.78
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD. 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 521.10 56.34 4.78 5526.59 118.35 552.90

    PANACEA BIOTEC LTD shareholding pattern

    Holding
    23.95%
    72.47%
    1.59%
    1.96%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    PANACEA BIOTEC LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    539.30 0.32 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 541.80
    • 26 Days 527.30
    • 10 Days 542.70
    • 50 Days 491.40
    • 12 Days 542.20
    • 100 Days 447.40
    • 20 Days 535.50
    • 200 Days 417.90
    552.17 PIVOT
    First Support 540.43 First Resistance 558.33 Second Support 534.27 Second Resistance 570.07 Third Support 522.53 Third Resistance 576.23
    RSI 56.70 ADX 54.14 MACD 17.94 Williams % R -65.67 Commodity Channel Index (CCI) 57.98
    Date 2026-07-10 Week 85408.00 Same Day 48243.00 Month 136276.00
    1 Year 1.01 3 Year 1.00
    Over 1 Month
    -0.07% down
    Over 1 Year
    33.97% down
    Over 3 Months
    67.07% down
    Over 3 Years
    63.50% down
    Over 6 Months
    33.52% down
    Over 5 Years
    7.83% down

    PANACEA BIOTEC LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2011 0.75 Final 21 Sep 2011 Equity shares
    16 Sep 2010 0.25 Final 20 Sep 2010 Equity shares
    19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
    21 Sep 2007 1.0 Final 25 Sep 2007 Equity shares
    12 Aug 2005 0.0 Final 17 Aug 2005 Equity shares
    Ex-Date Old FV NEW FV Record Date
    03 Feb 2003 10.0 1.0 11 Feb 2003
    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2011 0.75 Final 21 Sep 2011 Equity shares
    16 Sep 2010 0.25 Final 20 Sep 2010 Equity shares
    19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
    21 Sep 2007 1.0 Final 25 Sep 2007 Equity shares
    12 Aug 2005 0.0 Final 17 Aug 2005 Equity shares
    Ex-Date Old FV NEW FV Record Date
    03 Feb 2003 10.0 1.0 11 Feb 2003

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Panacea Biotec Ltd?

    Answer Field

    Panacea Biotec Ltd share price is for NSE ₹ 539.50 & for BSE ₹ 538.25 as on Jul 15 2026 02:13 PM.

    What is the Market Cap of Panacea Biotec Ltd Share?

    Answer Field

    The market cap of Panacea Biotec Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 15 2026 02:13 PM.

    What is the 52 Week High and Low of Panacea Biotec Ltd?

    Answer Field

    The 52 Week High and Low of Panacea Biotec Ltd for NSE is ₹ 647.00 and ₹ 292.40 and for BSE is ₹ 647.50 and ₹ 293.10.

    What is 1 year return for Panacea Biotec Ltd?

    Answer Field

    The 1 year returns on the stock has been 26.40%.

    What is the P/E Ratio of Panacea Biotec Ltd Share?

    Answer Field

    As on Jul 15 2026 02:13 PM the price-to-earnings (PE) ratio for Panacea Biotec Ltd share is -110.18.

    What is the PB ratio of Panacea Biotec Ltd Share?

    Answer Field

    As on Jul 15 2026 02:13 PM, the price-to-book (PB) ratio for Panacea Biotec Ltd share is 46.56.

    How to Buy Panacea Biotec Ltd Share?

    Answer Field

    You can trade in Panacea Biotec Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Panacea Biotec Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Panacea Biotec Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Panacea Biotec Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |